NovoCure Ltd — Director's Dealing 2018

May 31, 2018

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: NovoCure Ltd (NVCR)
CIK: 0001645113
Period of Report: 2017-05-25

Reporting Person: PHILLIPS CHARLES G III (Director)

Non-Derivative Transactions

Date	Security	Code	Shares	Price	A/D	Holdings After	Ownership
2018-05-25	Ordinary Shares	M	50000	$6.72	Acquired	50000	Direct
2018-05-25	Ordinary Shares	S	50000	$30.3015	Disposed	0	Direct

Derivative Transactions

Date	Security	Exercise Price	Code	Shares	A/D	Expiration	Underlying	Ownership
2018-05-25	Options to Buy Ordinary Shares	$6.72	M	50000	Acquired	2022-09-28	Ordinary Shares (50000)	Direct

Footnotes

F1: On May 25, 2018, Mr. Phillips sold 50,000 shares in multiple trades at prices ranging from $30.125 to $30.625. The price reported above reflects the weighted average sale price. Mr. Phillips hereby undertakes to provide to the Staff, the issuer or any security holder of the issuer, upon request, full information regarding the number of shares and prices at which the transaction was effected.

F2: Options to buy 50,000 ordinary shares are vested and currently exercisable as of the date hereof.